findmyKOL

Temitayo Ogunleye, MD

Basic profile

University of Pennsylvania

ORCIDNPI
RegionPhiladelphia, PA · NortheastSpecialtyDermatologyFocusDermatology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Temitayo Ogunleye is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 63 publications with 424 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
63publications

Distinct works indexed by OpenAlex, matched via ORCID.

424citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    26%
    Azole Antifungal15.6%
    Ketoconazole100%
    Part D60 patients
    Tetracycline-class Drug3.5%
    Doxycycline Hyclate100%
    Part D<11 patients

    + 3 more classes in this area

  • Dermatology

    20.4%
    Corticosteroid10.7%
    Triamcinolone Acetonide100%
    Part D76 patients
    Interleukin-4 Receptor alpha Antagonist5.6%
    Dupixent Pen77%Dupixent Syringe23%
    Part D<11 patients

    + 2 more classes in this area

  • Sensory organs

    15.5%
    Corticosteroid15.5%
    Clobetasol Propionate83%Hydrocortisone17%
    Part D60 patients
Where care is delivered (Part B)10.8% facility · 89.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”